News

Filter

1 to 9 of 37 results

Forendo licenses fispemifene to Apricus in USA

20-10-2014

Finland-based Forendo Pharma, a Swedish firm Karolinska Development portfolio company, has entered into…

Apricus BiosciencesfispemifeneForendo PharmaGenito-urinaryKarolinska DevelopmentLicensingMen's HealthPharmaceuticalUSA

Kyorin grants R-Pharm exclusive rights to OAB drug imidafenacin in Russia

Kyorin grants R-Pharm exclusive rights to OAB drug imidafenacin in Russia

15-10-2014

Japanese drugmaker Kyorin Pharmaceutical and R-Pharm, one of Russia’s largest pharmaceutical producers,…

Genito-urinaryimidafenacinJapanKyorin PharmaceuticalsLicensingOno PharmaceuticalPharmaceuticalR-PharmRussiaStayblaUritos

IQWiG finds no added benefit for Astellas’ Betmiga

IQWiG finds no added benefit for Astellas’ Betmiga

04-09-2014

Japanese drug major Astellas Pharma's Betmiga (mirabegron), which has been approved in Germany since…

Astellas PharmaBetmigaGenito-urinaryGermanyPharmaceutical

Allergan acquires LiRIS program from TARIS Biomedical

Allergan acquires LiRIS program from TARIS Biomedical

14-08-2014

US drugmaker Allergan has closed a transaction to acquire worldwide rights to privately-held TARIS Biomedical’s…

AllerganGenito-urinaryGlobalLicensingLiRISPharmaceuticalTARIS Biomedical

India’s IPAB upholds Pfizer’s Detrol patent

India’s IPAB upholds Pfizer’s Detrol patent

27-03-2014

In a positive development for US drug giant Pfizer, India's Intellectual Property Appellate Board (IPAB)…

Asia-PacificDetrolGenito-urinaryIndiaPatentsPfizerPharmaceuticalRanbaxy Laboratories

Positive top-line Ph III results with ceftolozane/tazobactam in cUTI

25-11-2013

US biopharma company Cubist Pharmaceuticals has revealed positive top-line results from its pivotal Phase…

Antibiotics and Infectious diseasesceftolozaneCubist PharmaceuticalsGenito-urinaryPharmaceuticalResearchtazobactam

SOBI gains rights to distribute Ravicti in Middle East

01-10-2013

Swedish Orphan Biovitrum says Hyperion Therapeutics has granted it exclusive rights to distribute its…

Genito-urinaryHyperion TherapeuticsLicensingPharmaceuticalRavictiRest of the WorldSobiSwedish Orphan Biovitrum

UK MHRA licenses Allergan's Botox for use in patients with overactive bladder

11-09-2013

Botox (botulinum toxin type A), from US drugmaker Allergan (NYSE: AGN), has been licensed by the UK Medicines…

AllerganBotoxEuropeGenito-urinaryPharmaceuticalRegulation

1 to 9 of 37 results

COMPANY SPOTLIGHT

Menarini

Back to top